10 Best US Penny Stocks to Buy
On December 23, CNBC reported that Julie Biel, Chief Market Strategist at Kayne Anderson Rudnick, joined Fast Money to discuss where the Russell 2000 may be headed and what investors can expect from small...
Cytomx Therapeutics Inc. (CTMX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 11,065,662 | $35,299,462 | 1.36% | |
| 2. | Perceptive Advisors Joseph Edelman | 9,680,185 | $30,879,790 | +39% | 0.89% |
| 3. | OrbiMed Advisors Samuel Isaly | 8,461,500 | $26,992,185 | 0.63% | |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 7,692,300 | $24,538,437 | 1.2% | |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,250,826 | $13,560,135 | +23% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.55 | 5,000 | $7,750.00 | 5,142 | 2023-03-29 | Filing | |
| $10.33 | 9,000 | $92,970.00 | 9,979 | 2019-03-04 | Filing | |
| $12.00 | 3,000 | $36,000.00 | 3,000 | 2015-10-14 | Filing | |
| $12.00 | 5,000 | $60,000.00 | 5,000 | 2015-10-14 | Filing | |
| $12.00 | 5,000 | $60,000.00 | 5,000 | 2015-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.54 | 101,793 | $461,906.10 | 987,891 | 2025-11-06 | Filing | |
| $2.69 | 10,614 | $28,539.98 | 226,271 | 2025-06-16 | Filing | |
| $2.95 | 1,641 | $4,841.44 | 199,385 | 2025-06-13 | Filing | |
| $2.69 | 13,884 | $37,334.08 | 272,252 | 2025-06-16 | Filing | |
| $2.69 | 55,511 | $149,263.53 | 1,089,684 | 2025-06-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 592,696 | $2,524,885 | 0% | |
| 2. | 58,922 | $251,008 | 0.07% | |
| 3. | 53,243 | $226,815 | 0% | |
| 4. | 45,763 | $194,950 | 0.03% | |
| 5. | 25,000 | $106,500 | 0% |
News See All
Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress
On December 5, 2025, CytomX Therapeutics, Inc. (NASDAQ:CTMX) saw H.C.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
CX-2051 Momentum and An Expanding Oncology Pipeline Strengthen CytomX Therapeutics’ (CTMX) Investment Case
The Fly reported on November 11, 2025, that CytomX Therapeutics, Inc. (NASDAQ:CTMX)’s price target was raised from $5 to $10 by H.C. Wainwright’s Mitchell Kapoor.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Third Quarter 2025 Financial Results Call. Please be advised that today's call is being recorded.
Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX), Sets a $7 PT
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is one of the best stocks under $5 with highest upside potential.
14 Stocks Under $5 with Highest Upside Potential
On October 28, Paul Tudor Jones, Tudor Investment Corporation founder and CIO and Robin Hood Foundation founder and board member, appeared on CNBC’s 'Squawk Box' to talk about the latest trends in the...
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Second Quarter 2025 Financial Results Call. Please be advised that today's call is being recorded.
10 Best Performing Penny Stocks So Far in 2025
By midday Wednesday, July 23, 2025, the Russell 2000 was up 1.57% for the week. This compares to a 0.9% gain for the S&P 500.